26th Apr 2021 09:51
Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - Receives convertible loan note conversion notice from Mint Capital Advisors Ltd. Notice is in respect to GBP900,000 worth of notes issued on February 3. Hemogenyx to issue 29.9 million shares at conversion price of GBP0.03015 each.
Current stock price: 2.94 pence, down 16% on Monday
Year-to-date change: down 70%
By Eric Cunha; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Hemogenyx